Renal Cell Carcinoma — Trials

Renal Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,621 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 375
Recruiting: 193
Ph III recruiting: 14
Growth YoY: +1.2%
Industry share: 33%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 39.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (276)

clinicaltrialsPublishedShowing 51–63 of 63 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02324803	Phase II Study of Pazopanib as Second-line Treatment After Sunitinib in mRCC Patients	unknown	Phase 2	86	Southern China Urology Cancer ConsortiumOTHER	1	Dec 24, 2014	clinicaltrials
NCT01274273	Study of Interleukin-2, Interferon-alpha and Bevacizumab in Metastatic Kidney Cancer	unknown	Phase 2	118	University of AarhusOTHER	1	Dec 2, 2014	clinicaltrials